APA (7th ed.) Citation

Stein, A., Goekkurt, E., Al-Batran, S., Moosmann, N., Ettrich, T. J., Goetze, T., . . . Tintelnot, J. (2025). Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: A phase 2 trial. Nature medicine. https://doi.org/10.1038/s41591-025-03979-y

Chicago Style (17th ed.) Citation

Stein, Alexander, et al. "Perioperative Pembrolizumab, Trastuzumab and FLOT in HER2-positive Localized Esophagogastric Adenocarcinoma: A Phase 2 Trial." Nature Medicine 2025. https://doi.org/10.1038/s41591-025-03979-y.

MLA (9th ed.) Citation

Stein, Alexander, et al. "Perioperative Pembrolizumab, Trastuzumab and FLOT in HER2-positive Localized Esophagogastric Adenocarcinoma: A Phase 2 Trial." Nature Medicine, 2025, https://doi.org/10.1038/s41591-025-03979-y.